CA2092997A1 - Process for the synthesis of (4r-cis)-1, 1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1, 3-dioxane-4-acetate - Google Patents

Process for the synthesis of (4r-cis)-1, 1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1, 3-dioxane-4-acetate

Info

Publication number
CA2092997A1
CA2092997A1 CA002092997A CA2092997A CA2092997A1 CA 2092997 A1 CA2092997 A1 CA 2092997A1 CA 002092997 A CA002092997 A CA 002092997A CA 2092997 A CA2092997 A CA 2092997A CA 2092997 A1 CA2092997 A1 CA 2092997A1
Authority
CA
Canada
Prior art keywords
cyanomethyl
dimethylethyl
dioxane
cis
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002092997A
Other languages
French (fr)
Other versions
CA2092997C (en
Inventor
Alan Millar
Donald Eugene Butler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Alan Millar
Donald Eugene Butler
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alan Millar, Donald Eugene Butler, Warner-Lambert Company filed Critical Alan Millar
Publication of CA2092997A1 publication Critical patent/CA2092997A1/en
Application granted granted Critical
Publication of CA2092997C publication Critical patent/CA2092997C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Abstract

A process for the preparation of the compound of formula (I) which comprises treating a compound of formula (V) wher-ein L is halogen or (a), wherein Ar is aryl, with a compound of the formula (VI): M-CN. A second aspect of the present invention is a novel intermediate of formula (V).
CA002092997A 1990-10-17 1991-09-11 Process for the synthesis of (4r-cis)-1, 1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1, 3-dioxane-4-acetate Expired - Fee Related CA2092997C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/599,521 US5103024A (en) 1990-10-17 1990-10-17 Process for the synthesis of (4r-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
US599,521 1990-10-17
PCT/US1991/006697 WO1992006968A1 (en) 1990-10-17 1991-09-11 Process for the synthesis of (4r-cis)-1,1-dimethylethyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate

Publications (2)

Publication Number Publication Date
CA2092997A1 true CA2092997A1 (en) 1992-04-18
CA2092997C CA2092997C (en) 2002-05-14

Family

ID=24399962

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002092997A Expired - Fee Related CA2092997C (en) 1990-10-17 1991-09-11 Process for the synthesis of (4r-cis)-1, 1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1, 3-dioxane-4-acetate

Country Status (20)

Country Link
US (1) US5103024A (en)
EP (1) EP0553213B1 (en)
JP (1) JP3105923B2 (en)
KR (1) KR0166385B1 (en)
AT (1) ATE118772T1 (en)
AU (1) AU646311B2 (en)
CA (1) CA2092997C (en)
CZ (5) CZ283003B6 (en)
DE (1) DE69107622T2 (en)
DK (1) DK0553213T3 (en)
ES (1) ES2070519T3 (en)
FI (1) FI108539B (en)
HK (1) HK1005026A1 (en)
HU (2) HU219237B (en)
IE (1) IE62940B1 (en)
NO (1) NO301588B1 (en)
PT (1) PT99244B (en)
RU (1) RU2067580C1 (en)
SK (5) SK280938B6 (en)
WO (1) WO1992006968A1 (en)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149837A (en) * 1988-02-22 1992-09-22 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
US5245047A (en) * 1988-02-22 1993-09-14 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
US5298627A (en) * 1993-03-03 1994-03-29 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
HRP960312B1 (en) 1995-07-17 2001-10-31 Warner Lambert Co NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS /R-(R*, R*)/-2-(4-FLUOROPHENYL)-"beta", "delta"-DIHYDROXY-5-PHENYL-4-/(PHENYLAMINO)CARBONYL/-1H-PYRROLE -1-HEPTANOIC ACID CALCIUM SALT (2 : 1)
US6087511A (en) * 1996-07-16 2000-07-11 Warner-Lambert Company Process for the production of amorphous [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl )-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid) calcium salt (2:1)
HUP0103659A3 (en) * 1998-04-30 2003-01-28 Kaneka Corp Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives
HU227840B1 (en) * 1999-05-06 2012-05-02 Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag Intermediates of atorvastatin synthesis and process for producing them
IN191236B (en) * 1999-05-25 2003-10-11 Ranbaxy Lab Ltd
US20040063969A1 (en) * 1999-10-18 2004-04-01 Egis Gyogyszergyar Rt. Process for the preparation of amorphous atorvastatin calcium
MXPA02004082A (en) * 1999-12-17 2002-10-11 Warner Lambert Res & Dev A process for producing crystalline atorvastatin calcium.
ES2252088T3 (en) 1999-12-17 2006-05-16 Pfizer Science And Technology Ireland Limited PROCEDURE OF INDUSTRIAL SCALE PRODUCTION OF THE CALCIUM HEMISAL OF ATORVASTATIN CRYSTAL HYDROCHLATE.
US20040014195A1 (en) * 1999-12-29 2004-01-22 Diversa Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7608445B1 (en) 1999-12-29 2009-10-27 Verenium Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7521216B2 (en) * 1999-12-29 2009-04-21 Verenium Corporation Nitrilases and methods for making and using them
US7300775B2 (en) * 1999-12-29 2007-11-27 Verenium Corporation Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents
JP3844112B2 (en) 2000-08-23 2006-11-08 高砂香料工業株式会社 3,5,6-Trihydroxyhexanoic acid ammonium salt derivative and method for producing the same
US6476235B2 (en) * 2001-01-09 2002-11-05 Warner-Lambert Company Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
EP1734034A3 (en) 2001-01-09 2007-01-03 Warner-Lambert Company LLC Carboxylic acid salts of beta-alanine esters or -amides
WO2002057229A1 (en) * 2001-01-19 2002-07-25 Biocon India Limited FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß,$G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN)
SI20814A (en) * 2001-01-23 2002-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Preparation of amorphous atorvastatin
SI20848A (en) 2001-03-14 2002-10-31 Lek, Tovarna Farmacevtskih In Kemijskih Izdelkov, D.D. Pharmaceutical formulation containing atorvastatin calcium
HUP0400381A2 (en) 2001-06-29 2004-09-28 Warner-Lambert Company Llc Crystalline forms of r-(r*,r*)-2-(4-fluorphenyl)-betha, delta dihydroxy-5-(1-methylethyl)-3-phenyl-4-phenylaminocarbonyl-iii-pyrrole-1-heptanoic acid calcium salt (2:1)(atorvastatin)
GB0116212D0 (en) * 2001-07-03 2001-08-29 Avecia Ltd Process
MXPA04000889A (en) 2001-07-30 2004-06-03 Reddys Lab Ltd Dr Crystalline forms vi and vii of atorvastatin calcium.
PE20030324A1 (en) * 2001-07-31 2003-04-03 Warner Lambert Co PHARMACEUTICAL COMPOSITIONS OF AMLODIPINE AND ATORVASTATIN
WO2003018547A2 (en) * 2001-08-31 2003-03-06 Morepen Laboratories Ltd. An improved process for the preparation of amorphous atorvastatin calcium salt (2:1)
HU227124B1 (en) * 2001-09-14 2010-07-28 Egis Gyogyszergyar Nyilvanosan Polymorphs of 1-pyrrole derivative, intermediate for the preparation of atorvastatin
UA77990C2 (en) * 2001-12-12 2007-02-15 Crystalline calcium salt of (2:1) [r-(r*,r*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrroleheptanic acid
CZ296967B6 (en) * 2002-02-01 2006-08-16 Zentiva, A.S. Process for preparing amorphous form of hemicalcium salt of (3R,5R)7-[3-phenyl-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropylpyrrol-l-yl]-3,5-dihydroxyheptanoic acid (atorvastatin)
DE10212492B4 (en) * 2002-03-21 2012-02-02 Daimler Ag piston pump
AU2003251523A1 (en) 2002-06-13 2003-12-31 Diversa Corporation Processes for making (r)-ethyl 4-cyano-3-hydroxybutyric acid
BR0313246A (en) * 2002-08-06 2005-06-14 Warner Lambert Co Process for Preparation of 5- (4-Fluorphenyl) -1- [2 - ((2r, 4r) -4-hydroxy-6-oxo-tetrahydro-pyan-2-yl) ethyl] -2-isopropyl acid phenylamide -4-phenyl-1h-pyrrol-3-carbocyclic
CA2491051A1 (en) * 2002-09-03 2004-03-18 Morepen Laboratories Limited Atorvastatin calcium form vi or hydrates thereof
KR100529703B1 (en) * 2002-09-23 2005-11-17 임광민 Chiral intermediate, process for the production thereof, and process for the production of atorvastatin
HRP20020885B1 (en) * 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
KR100780984B1 (en) * 2003-04-14 2007-11-29 워너-램버트 캄파니 엘엘씨 Process for Preparing 5-4-Fluorophenyl-1-[2-2R,4R-4-hydroxy-6-oxo-tetrahydro-pyran-2-ylethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
US20040248972A1 (en) * 2003-05-16 2004-12-09 Ambit Biosciences Corporation Compounds and uses thereof
WO2004103959A2 (en) * 2003-05-16 2004-12-02 Ambit Biosciences Corporation Heterocyclic compounds and uses thereof
US20050182125A1 (en) * 2003-05-16 2005-08-18 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
US7790197B2 (en) * 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
US20050271717A1 (en) * 2003-06-12 2005-12-08 Alfred Berchielli Pharmaceutical compositions of atorvastatin
US7655692B2 (en) * 2003-06-12 2010-02-02 Pfizer Inc. Process for forming amorphous atorvastatin
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
WO2005012246A1 (en) * 2003-07-25 2005-02-10 Avecia Pharmaceuticals Limited Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin
RU2315755C2 (en) * 2003-09-17 2008-01-27 Уорнер-Ламберт Компани Ллс Crystalline forms of [r[(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrol-1-heptanoic acid
CA2456430A1 (en) * 2004-01-28 2005-07-28 Brantford Chemicals Inc. Improved process for the preparation of amorphous atorvastatin calcium
SI1727795T1 (en) 2004-03-17 2012-05-31 Ranbaxy Lab Ltd Process for the production of atorvastatin calcium in amorphous form
CN1960972A (en) * 2004-04-16 2007-05-09 辉瑞产品公司 Process for forming amorphous atorvastatin calcium
CA2649054A1 (en) 2004-05-05 2005-11-10 Pfizer Products Inc. Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
CA2833770A1 (en) * 2004-07-16 2006-01-26 Lek Pharmaceuticals D.D Oxidative degradation products of atorvastatin calcium
CA2672554C (en) 2004-07-20 2012-01-03 Warner-Lambert Company Llc Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl).beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1)
CA2578722C (en) * 2004-08-27 2010-02-02 Biocon Limited Process for atorvastatin calcium amorphous
EP1807055A1 (en) * 2004-10-28 2007-07-18 Warner-Lambert Company LLC Process for forming amorphous atorvastatin
EP1814541A4 (en) 2004-11-22 2009-10-28 Dexcel Pharma Technologies Ltd Stable atorvastatin formulations
JP2008521878A (en) * 2004-12-02 2008-06-26 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Pharmaceutical composition of amorphous atorvastatin and process for its production
CA2621506A1 (en) * 2005-09-09 2007-03-15 Pfizer Science And Technology Ireland Limited Preparation of an atorvastatin intermediate
JP2009507822A (en) * 2005-09-09 2009-02-26 ファイザー・サイエンス・アンド・テクノロジー・アイルランド・リミテッド Preparation of atorvastatin intermediate
US20090216029A1 (en) * 2005-09-16 2009-08-27 Yatendra Kumar Process for the production of atorvastatin calcium in amorphous form
CA2547216A1 (en) 2005-09-21 2007-03-21 Renuka D. Reddy Process for annealing amorphous atorvastatin
WO2007057755A1 (en) 2005-11-21 2007-05-24 Warner-Lambert Company Llc Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium
EP1810667A1 (en) 2006-01-20 2007-07-25 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising amorphous atorvastatin
WO2008053312A2 (en) * 2006-11-02 2008-05-08 Cadila Pharmaceuticals Limited Process for preparing amorphous atorvastatin hemi calcium salt and its intermediate
US7834195B2 (en) * 2007-01-24 2010-11-16 Apotex Pharmachem Inc. Atorvastatin calcium propylene glycol solvates
DK2115153T3 (en) 2007-03-01 2013-09-08 Bp Corp North America Inc Nitrilases, nucleic acids encoding them, and methods of preparing and using them
WO2009013633A2 (en) * 2007-07-20 2009-01-29 Actavis Group Ptc Ehf Amorphous coprecipitates of atorvastatin pharmaceutically acceptable salts
EP2075246A1 (en) 2007-12-27 2009-07-01 M. J. Institute of Research A process for preparation of amorphous form of atorvastatin hemi-calcium salt
US8115015B2 (en) * 2009-01-26 2012-02-14 Cadila Healthcare Limited Process for the preparation of amorphous atorvastatin calcium
WO2012032035A1 (en) 2010-09-09 2012-03-15 Dsm Sinochem Pharmaceuticals Netherlands B.V. Salts of 7-amino-3,5-dihydroxyheptanoic acid esters
CN103702982A (en) 2011-07-01 2014-04-02 中化帝斯曼制药有限公司荷兰公司 Micronized crystals of atorvastatin hemicalcium
WO2016056031A1 (en) 2014-10-08 2016-04-14 Council Of Scientific & Industrial Research Novel diol compounds synthesis and its use for formal synthesis of (2r, 3 s)-3-hydroxypipecolic acid
CN106008251A (en) * 2016-05-19 2016-10-12 河南豫辰药业股份有限公司 Preparation method of 2-benzylidene isobutyryl acetanilide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US5003080A (en) * 1988-02-22 1991-03-26 Warner-Lambert Company Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives
DE3929913A1 (en) * 1989-09-08 1991-04-04 Hoechst Ag 4-HYDROXYTETRAHYDROPYRAN-2-ONE AND THE CORRESPONDING DIHYDROXYCARBONSAEUREDERIVATES, SALTS AND ESTERS, PROCESS FOR THEIR PREPARATION, THEIR USE AS A MEDICAMENT, PHARMACEUTICAL PREPARATES AND PREPARED PRODUCTS

Also Published As

Publication number Publication date
PT99244B (en) 1999-04-30
CZ61493A3 (en) 1994-02-16
FI931680A0 (en) 1993-04-14
EP0553213A1 (en) 1993-08-04
SK280941B6 (en) 2000-09-12
JP3105923B2 (en) 2000-11-06
WO1992006968A1 (en) 1992-04-30
HU9701183D0 (en) 1997-09-29
ES2070519T3 (en) 1995-06-01
AU646311B2 (en) 1994-02-17
CZ282994B6 (en) 1997-12-17
CZ124597A3 (en) 1997-12-17
CZ282922B6 (en) 1997-11-12
HU219237B (en) 2001-03-28
EP0553213B1 (en) 1995-02-22
SK280938B6 (en) 2000-09-12
NO931421D0 (en) 1993-04-16
CZ124697A3 (en) 1997-12-17
JPH06502162A (en) 1994-03-10
CA2092997C (en) 2002-05-14
HK1005026A1 (en) 1998-12-18
FI931680A (en) 1993-04-14
KR930702328A (en) 1993-09-08
HU213731B (en) 1997-09-29
KR0166385B1 (en) 1999-01-15
CZ209495A3 (en) 1997-12-17
AU8848091A (en) 1992-05-20
IE62940B1 (en) 1995-03-08
DE69107622D1 (en) 1995-03-30
SK280942B6 (en) 2000-09-12
US5103024A (en) 1992-04-07
DK0553213T3 (en) 1995-07-17
FI108539B (en) 2002-02-15
SK280940B6 (en) 2000-09-12
SK280939B6 (en) 2000-09-12
RU2067580C1 (en) 1996-10-10
IE913629A1 (en) 1992-04-22
NO931421L (en) 1993-06-16
CZ282992B6 (en) 1997-12-17
NO301588B1 (en) 1997-11-17
PT99244A (en) 1992-09-30
DE69107622T2 (en) 1995-07-06
CZ124797A3 (en) 1997-12-17
HUT64049A (en) 1993-11-29
SK33993A3 (en) 1993-10-06
HU9301122D0 (en) 1993-08-30
CZ283003B6 (en) 1997-12-17
ATE118772T1 (en) 1995-03-15
CZ282993B6 (en) 1997-12-17

Similar Documents

Publication Publication Date Title
CA2092997A1 (en) Process for the synthesis of (4r-cis)-1, 1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1, 3-dioxane-4-acetate
CA2035972A1 (en) Process for the preparation of oxetanones
HUT64310A (en) Compositions containing substituted aryl-halogenalkyl-pyrazol derivatives having herbicidal activity and process for producing said compounds
NO992549D0 (en) Sugar compound, gelling agent and process for preparation thereof
CA2302058A1 (en) A process for preparing 5-methoxy-4-methyl-2,4-dihydro-3h-1,2,4-triazol-3-one
HU910847D0 (en) Process for producing chloro-triazole derivatives
CA2051693A1 (en) Allosteric hemoglobin modifiers
AU747521C (en) Cycloalkene derivatives, process for producing the same, and use
UA27220C2 (en) method for obtaining derivatives of 1-phenylimidazoline-2,5-dione
NO851932L (en) PROCEDURE FOR PREPARING BETA-CARBOLIN-3-OXADIAZOLYL DERIVATIVES.
TW237483B (en)
MY116862A (en) New processes for preparing pesticidal intermediates
CA2170645A1 (en) Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-14-indole-5-ethanesulphonamide
EP1148047A3 (en) Processes for preparing cyclic compounds
AU5299890A (en) Process for the synthesis of acylamino organosilicon compounds
EP0374410A3 (en) 2-Azabicyclo[2.2.1]hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of N-phosphonomethylglycine
ZA91288B (en) Coating compound,process for its production as well as use thereof
EP1199308A3 (en) Process for the preparation of imidazodiazepine intermediates
TW357056B (en) Herbicides
CA2001083A1 (en) Novel s-timolol derivative and process for its preparation
AU1855088A (en) Treating agent for heart failure
ATE247641T1 (en) PYRIDINE INTERMEDIATE PRODUCTS USABLE FOR PRODUCING BETA-ADRENERGIC RECEPTOR AGONISTS
WO2000003681A3 (en) Process for the synthesis of benzopyran derivatives
CA2090976A1 (en) Herbicidal substituted bicyclic triazoles
NO942964L (en) Process for the preparation of chiral ethyl (5-amino-1,2-dihydro-2-methyl-3-phenylpyrido [3,4-ba- pyrazin-7-yl) carbamate

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed